OR WAIT 15 SECS
Andrew Bowser is a medical writer based in Brooklyn, New York.
May 11, 2018
Photos taken by parents and submitted by smartphone are usually of sufficient quality to allow accurate diagnosis of some common pediatric skin conditions, results of a recent study in JAMA Dermatology suggests.
March 30, 2018
Today, medical practices are considering cloud services for everything from revenue cycle management to patient engagement tools. HIMSS Analytics reports that the number of healthcare provider organizations planning to use the cloud for back office functions has jumped from 22-46% within two years.
February 20, 2018
Diagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.
February 19, 2018
While the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.
With one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.
Not all biologic treatments are equal. Side effects, effectiveness, cost and administration style are among factors physicians should consider when switching treatments, experts report at AAD 2018.
February 18, 2018
This week during the annual meeting of the American Academy of Dermatology in San Diego, Robert Sidbury, M.D., addressed developments in atopic dermatitis treatments since the publication of treatment guidelines in 2014.
February 17, 2018
Combination treatments to reduce scarring have been shown to be effective without the need for aggressive surgical techniques that can lead to suboptimal results, researchers reported at AAD 2018 this week.
Female patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.
February 16, 2018
Systemic disease among patients with discoid lupus erythematosus, a chronic form of cutaneous lupus, can develop within one to two years of initial diagnosis, says Joseph F. Merola, M.D., reporting at the American Academy of Dermatology annual meeting in San Diego.
